| 3.4 |
17.1 |
GO:0015688 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 3.4 |
10.2 |
GO:0071629 |
cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 2.6 |
2.6 |
GO:0090343 |
positive regulation of cell aging(GO:0090343) |
| 2.5 |
7.4 |
GO:0002416 |
IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 2.4 |
2.4 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 2.4 |
12.1 |
GO:1904245 |
regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
| 2.2 |
11.2 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 2.2 |
6.7 |
GO:2000625 |
regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
| 2.0 |
2.0 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 1.9 |
5.8 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 1.9 |
9.5 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 1.8 |
5.5 |
GO:0034148 |
regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
| 1.8 |
7.3 |
GO:1904199 |
positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
| 1.8 |
7.2 |
GO:0009447 |
putrescine catabolic process(GO:0009447) |
| 1.7 |
10.3 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 1.7 |
5.1 |
GO:0035674 |
tricarboxylic acid transmembrane transport(GO:0035674) |
| 1.7 |
5.0 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 1.6 |
6.5 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 1.6 |
1.6 |
GO:2000276 |
negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 1.6 |
6.4 |
GO:1904106 |
protein localization to microvillus(GO:1904106) |
| 1.6 |
8.0 |
GO:1903412 |
response to bile acid(GO:1903412) |
| 1.5 |
4.6 |
GO:0003192 |
mitral valve formation(GO:0003192) |
| 1.5 |
4.5 |
GO:0014876 |
response to injury involved in regulation of muscle adaptation(GO:0014876) |
| 1.5 |
3.0 |
GO:2000182 |
regulation of progesterone biosynthetic process(GO:2000182) |
| 1.5 |
13.1 |
GO:0046618 |
drug export(GO:0046618) |
| 1.5 |
4.4 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 1.4 |
11.6 |
GO:2000860 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 1.4 |
5.7 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 1.4 |
8.6 |
GO:1902462 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 1.4 |
4.3 |
GO:0060796 |
regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
| 1.4 |
7.1 |
GO:0009440 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 1.4 |
5.5 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 1.4 |
9.5 |
GO:0010609 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 1.3 |
8.0 |
GO:0030421 |
defecation(GO:0030421) |
| 1.3 |
13.3 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 1.3 |
5.3 |
GO:0002268 |
follicular dendritic cell differentiation(GO:0002268) |
| 1.3 |
6.5 |
GO:1904845 |
response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 1.3 |
3.8 |
GO:1990575 |
mitochondrial L-ornithine transmembrane transport(GO:1990575) |
| 1.3 |
3.8 |
GO:2000412 |
positive regulation of thymocyte migration(GO:2000412) |
| 1.3 |
5.0 |
GO:1904398 |
positive regulation of neuromuscular junction development(GO:1904398) |
| 1.3 |
1.3 |
GO:0002582 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 1.3 |
6.3 |
GO:2000110 |
negative regulation of macrophage apoptotic process(GO:2000110) |
| 1.3 |
3.8 |
GO:0060265 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 1.2 |
1.2 |
GO:0090116 |
C-5 methylation of cytosine(GO:0090116) |
| 1.2 |
3.7 |
GO:0021919 |
BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 1.2 |
3.7 |
GO:0036481 |
intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
| 1.2 |
6.1 |
GO:0003070 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 1.2 |
3.6 |
GO:0042450 |
arginine biosynthetic process via ornithine(GO:0042450) |
| 1.2 |
2.4 |
GO:1901656 |
glycoside transport(GO:1901656) |
| 1.2 |
2.4 |
GO:0045448 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 1.2 |
4.7 |
GO:0072287 |
metanephric distal tubule morphogenesis(GO:0072287) |
| 1.1 |
4.5 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 1.1 |
3.4 |
GO:0001579 |
medium-chain fatty acid transport(GO:0001579) |
| 1.1 |
1.1 |
GO:0046351 |
disaccharide biosynthetic process(GO:0046351) |
| 1.1 |
6.7 |
GO:0009137 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 1.1 |
4.5 |
GO:0048687 |
modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 1.1 |
4.5 |
GO:0035054 |
embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 1.1 |
3.3 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 1.1 |
3.2 |
GO:0006258 |
UDP-glucose catabolic process(GO:0006258) |
| 1.1 |
2.1 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 1.1 |
1.1 |
GO:0014741 |
negative regulation of muscle hypertrophy(GO:0014741) |
| 1.1 |
1.1 |
GO:0001560 |
regulation of cell growth by extracellular stimulus(GO:0001560) |
| 1.0 |
3.1 |
GO:0097195 |
pilomotor reflex(GO:0097195) |
| 1.0 |
15.7 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 1.0 |
9.4 |
GO:0009227 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 1.0 |
3.1 |
GO:0099558 |
maintenance of synapse structure(GO:0099558) |
| 1.0 |
3.1 |
GO:1901076 |
positive regulation of engulfment of apoptotic cell(GO:1901076) |
| 1.0 |
1.0 |
GO:0030220 |
platelet formation(GO:0030220) |
| 1.0 |
4.1 |
GO:0090299 |
regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 1.0 |
5.1 |
GO:0098502 |
DNA dephosphorylation(GO:0098502) |
| 1.0 |
3.1 |
GO:1900108 |
negative regulation of nodal signaling pathway(GO:1900108) |
| 1.0 |
3.1 |
GO:0048320 |
axial mesoderm formation(GO:0048320) |
| 1.0 |
3.0 |
GO:0019516 |
lactate oxidation(GO:0019516) |
| 1.0 |
8.0 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 1.0 |
6.0 |
GO:0090034 |
regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 1.0 |
6.0 |
GO:0033132 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 1.0 |
5.9 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 1.0 |
5.9 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 1.0 |
2.9 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 1.0 |
1.0 |
GO:0060629 |
regulation of homologous chromosome segregation(GO:0060629) |
| 1.0 |
8.6 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 1.0 |
5.7 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.9 |
7.5 |
GO:0035865 |
cellular response to potassium ion(GO:0035865) |
| 0.9 |
3.8 |
GO:0022007 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.9 |
1.9 |
GO:0090119 |
vesicle-mediated cholesterol transport(GO:0090119) |
| 0.9 |
3.7 |
GO:0010900 |
negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.9 |
1.9 |
GO:0060324 |
face development(GO:0060324) |
| 0.9 |
0.9 |
GO:0036309 |
protein localization to M-band(GO:0036309) |
| 0.9 |
0.9 |
GO:1902995 |
regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 0.9 |
6.5 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.9 |
5.5 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.9 |
2.7 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.9 |
7.3 |
GO:0038195 |
urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.9 |
3.6 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.9 |
2.7 |
GO:1902463 |
protein localization to cell leading edge(GO:1902463) |
| 0.9 |
2.7 |
GO:1903461 |
Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 0.9 |
3.5 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.9 |
2.6 |
GO:0061727 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.9 |
5.3 |
GO:0019542 |
acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
| 0.9 |
4.4 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.9 |
4.4 |
GO:0061737 |
leukotriene signaling pathway(GO:0061737) |
| 0.9 |
2.6 |
GO:0060856 |
establishment of blood-brain barrier(GO:0060856) |
| 0.9 |
3.4 |
GO:0030920 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.8 |
1.7 |
GO:0072021 |
ascending thin limb development(GO:0072021) metanephric ascending thin limb development(GO:0072218) |
| 0.8 |
0.8 |
GO:0032425 |
positive regulation of mismatch repair(GO:0032425) |
| 0.8 |
3.3 |
GO:0090031 |
positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 0.8 |
4.2 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 0.8 |
2.5 |
GO:1903401 |
L-lysine transmembrane transport(GO:1903401) |
| 0.8 |
0.8 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.8 |
10.7 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.8 |
0.8 |
GO:1904397 |
negative regulation of neuromuscular junction development(GO:1904397) |
| 0.8 |
2.4 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.8 |
0.8 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.8 |
2.4 |
GO:0075071 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.8 |
0.8 |
GO:0045608 |
negative regulation of auditory receptor cell differentiation(GO:0045608) |
| 0.8 |
3.2 |
GO:0098968 |
neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.8 |
4.8 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.8 |
0.8 |
GO:0061355 |
Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
| 0.8 |
0.8 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.8 |
6.3 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.8 |
1.6 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.8 |
1.6 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.8 |
3.9 |
GO:0052042 |
induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
| 0.8 |
5.5 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.8 |
1.6 |
GO:0097066 |
response to thyroid hormone(GO:0097066) |
| 0.8 |
3.1 |
GO:0035425 |
autocrine signaling(GO:0035425) |
| 0.8 |
9.4 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.8 |
5.5 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.8 |
4.7 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.8 |
3.1 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.8 |
4.7 |
GO:0019747 |
regulation of isoprenoid metabolic process(GO:0019747) |
| 0.8 |
3.1 |
GO:1903719 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.8 |
0.8 |
GO:0002664 |
lymphocyte anergy(GO:0002249) regulation of T cell tolerance induction(GO:0002664) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.8 |
0.8 |
GO:2000630 |
positive regulation of miRNA metabolic process(GO:2000630) |
| 0.8 |
3.0 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.8 |
0.8 |
GO:1903566 |
positive regulation of protein localization to cilium(GO:1903566) |
| 0.8 |
0.8 |
GO:0032290 |
peripheral nervous system myelin formation(GO:0032290) |
| 0.8 |
2.3 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.7 |
2.2 |
GO:1990697 |
protein depalmitoleylation(GO:1990697) |
| 0.7 |
3.7 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.7 |
3.0 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.7 |
11.0 |
GO:0010182 |
hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
| 0.7 |
9.6 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.7 |
2.9 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 0.7 |
2.2 |
GO:1901207 |
regulation of heart looping(GO:1901207) |
| 0.7 |
0.7 |
GO:0003241 |
growth involved in heart morphogenesis(GO:0003241) |
| 0.7 |
2.9 |
GO:1903939 |
regulation of TORC2 signaling(GO:1903939) |
| 0.7 |
2.9 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
| 0.7 |
5.8 |
GO:0036018 |
response to erythropoietin(GO:0036017) cellular response to erythropoietin(GO:0036018) |
| 0.7 |
1.4 |
GO:0010621 |
negative regulation of transcription by transcription factor localization(GO:0010621) |
| 0.7 |
2.2 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.7 |
4.3 |
GO:0061143 |
alveolar primary septum development(GO:0061143) |
| 0.7 |
2.2 |
GO:0061394 |
regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.7 |
5.0 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 0.7 |
3.6 |
GO:0000430 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.7 |
2.1 |
GO:2001226 |
negative regulation of chloride transport(GO:2001226) |
| 0.7 |
3.5 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.7 |
2.1 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.7 |
2.8 |
GO:0006850 |
mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.7 |
2.1 |
GO:2000820 |
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 0.7 |
1.4 |
GO:0060584 |
regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.7 |
2.1 |
GO:0046081 |
dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.7 |
0.7 |
GO:0001977 |
renal system process involved in regulation of blood volume(GO:0001977) |
| 0.7 |
6.2 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.7 |
2.1 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.7 |
2.7 |
GO:0034499 |
late endosome to Golgi transport(GO:0034499) |
| 0.7 |
2.7 |
GO:0034444 |
regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.7 |
4.0 |
GO:0010716 |
negative regulation of extracellular matrix disassembly(GO:0010716) |
| 0.7 |
4.0 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.7 |
2.7 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.7 |
0.7 |
GO:0046320 |
regulation of fatty acid oxidation(GO:0046320) |
| 0.7 |
2.0 |
GO:2000397 |
regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.7 |
1.3 |
GO:0003420 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.7 |
2.0 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
| 0.7 |
4.0 |
GO:0070221 |
sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.7 |
10.5 |
GO:0051006 |
positive regulation of lipoprotein lipase activity(GO:0051006) |
| 0.7 |
11.8 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.7 |
0.7 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.7 |
3.3 |
GO:1904636 |
response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.7 |
2.6 |
GO:0044691 |
tooth eruption(GO:0044691) |
| 0.7 |
2.6 |
GO:0071348 |
cellular response to interleukin-11(GO:0071348) |
| 0.6 |
11.7 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.6 |
1.3 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.6 |
3.9 |
GO:0043128 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.6 |
1.9 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 0.6 |
3.2 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 0.6 |
1.9 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.6 |
2.5 |
GO:0052651 |
monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.6 |
1.9 |
GO:0002731 |
negative regulation of dendritic cell cytokine production(GO:0002731) |
| 0.6 |
1.3 |
GO:0071672 |
negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
| 0.6 |
2.5 |
GO:0071393 |
cellular response to progesterone stimulus(GO:0071393) |
| 0.6 |
1.9 |
GO:0006524 |
alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.6 |
0.6 |
GO:0060623 |
regulation of chromosome condensation(GO:0060623) |
| 0.6 |
8.0 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.6 |
1.8 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.6 |
3.1 |
GO:0035751 |
regulation of lysosomal lumen pH(GO:0035751) |
| 0.6 |
1.8 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.6 |
1.8 |
GO:0060723 |
spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.6 |
4.9 |
GO:0036148 |
phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.6 |
5.4 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.6 |
1.8 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.6 |
1.8 |
GO:0014707 |
branchiomeric skeletal muscle development(GO:0014707) |
| 0.6 |
1.2 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.6 |
2.4 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.6 |
1.2 |
GO:0060431 |
primary lung bud formation(GO:0060431) |
| 0.6 |
2.3 |
GO:2000777 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.6 |
2.3 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.6 |
7.6 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.6 |
7.0 |
GO:0070294 |
renal sodium ion absorption(GO:0070294) |
| 0.6 |
3.5 |
GO:0035992 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.6 |
5.2 |
GO:0045591 |
positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.6 |
1.1 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.6 |
2.9 |
GO:0048807 |
female genitalia morphogenesis(GO:0048807) |
| 0.6 |
2.3 |
GO:1990926 |
short-term synaptic potentiation(GO:1990926) |
| 0.6 |
3.4 |
GO:1902499 |
positive regulation of protein autoubiquitination(GO:1902499) |
| 0.6 |
1.1 |
GO:0014016 |
neuroblast differentiation(GO:0014016) |
| 0.6 |
0.6 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.6 |
1.7 |
GO:2001033 |
negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.6 |
3.4 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.6 |
0.6 |
GO:0090346 |
cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.6 |
3.9 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.6 |
1.7 |
GO:0035623 |
renal glucose absorption(GO:0035623) |
| 0.6 |
1.7 |
GO:0032581 |
ER-dependent peroxisome organization(GO:0032581) |
| 0.6 |
3.9 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.6 |
0.6 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.6 |
7.9 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.6 |
6.7 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.6 |
2.8 |
GO:0046813 |
receptor-mediated virion attachment to host cell(GO:0046813) |
| 0.6 |
7.3 |
GO:2000680 |
rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.6 |
1.7 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.6 |
7.2 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.6 |
1.7 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.6 |
1.1 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.6 |
1.7 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.6 |
0.6 |
GO:1903874 |
ferrous iron transport(GO:0015684) ferrous iron import(GO:0070627) ferrous iron transmembrane transport(GO:1903874) |
| 0.5 |
1.1 |
GO:0003183 |
mitral valve morphogenesis(GO:0003183) |
| 0.5 |
1.6 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.5 |
2.2 |
GO:0003335 |
corneocyte development(GO:0003335) |
| 0.5 |
0.5 |
GO:0019322 |
pentose biosynthetic process(GO:0019322) |
| 0.5 |
1.6 |
GO:0070902 |
mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 0.5 |
2.1 |
GO:0046882 |
negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
| 0.5 |
10.7 |
GO:0090023 |
positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.5 |
2.1 |
GO:0099640 |
axo-dendritic protein transport(GO:0099640) |
| 0.5 |
1.1 |
GO:0045013 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.5 |
3.2 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.5 |
6.4 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 0.5 |
3.7 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.5 |
2.1 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.5 |
1.6 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.5 |
3.7 |
GO:0010133 |
proline catabolic process(GO:0006562) proline catabolic process to glutamate(GO:0010133) |
| 0.5 |
0.5 |
GO:0021718 |
pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.5 |
4.2 |
GO:0097577 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.5 |
3.7 |
GO:0060671 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.5 |
1.0 |
GO:0021772 |
olfactory bulb development(GO:0021772) |
| 0.5 |
1.6 |
GO:0035740 |
CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 0.5 |
2.6 |
GO:0021604 |
cranial nerve structural organization(GO:0021604) |
| 0.5 |
7.2 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.5 |
6.2 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.5 |
1.0 |
GO:0051414 |
response to cortisol(GO:0051414) |
| 0.5 |
1.5 |
GO:0032811 |
regulation of epinephrine secretion(GO:0014060) negative regulation of epinephrine secretion(GO:0032811) epinephrine secretion(GO:0048242) |
| 0.5 |
1.5 |
GO:0021526 |
medial motor column neuron differentiation(GO:0021526) |
| 0.5 |
3.6 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.5 |
3.6 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
| 0.5 |
5.1 |
GO:0032226 |
positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
| 0.5 |
2.0 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.5 |
1.5 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 0.5 |
1.0 |
GO:0060122 |
inner ear receptor stereocilium organization(GO:0060122) |
| 0.5 |
5.0 |
GO:0097107 |
postsynaptic density assembly(GO:0097107) |
| 0.5 |
8.0 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.5 |
1.0 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.5 |
2.0 |
GO:0097360 |
chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.5 |
3.0 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.5 |
2.0 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.5 |
2.5 |
GO:0071409 |
cellular response to cycloheximide(GO:0071409) |
| 0.5 |
1.5 |
GO:1902598 |
creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.5 |
2.0 |
GO:0021966 |
corticospinal neuron axon guidance(GO:0021966) |
| 0.5 |
1.5 |
GO:1903463 |
regulation of mitotic cell cycle DNA replication(GO:1903463) |
| 0.5 |
3.9 |
GO:0090238 |
positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.5 |
0.5 |
GO:2000563 |
positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.5 |
1.0 |
GO:0046732 |
induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.5 |
2.9 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.5 |
1.0 |
GO:0072197 |
ureter morphogenesis(GO:0072197) |
| 0.5 |
1.9 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.5 |
3.3 |
GO:0060684 |
epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.5 |
1.4 |
GO:0048168 |
regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.5 |
2.8 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.5 |
1.4 |
GO:0042137 |
sequestering of neurotransmitter(GO:0042137) |
| 0.5 |
1.4 |
GO:0015680 |
intracellular copper ion transport(GO:0015680) |
| 0.5 |
4.7 |
GO:0060263 |
regulation of respiratory burst(GO:0060263) |
| 0.5 |
7.0 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.5 |
2.8 |
GO:0000050 |
urea cycle(GO:0000050) |
| 0.5 |
5.1 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.5 |
0.5 |
GO:0032898 |
neurotrophin production(GO:0032898) |
| 0.5 |
0.5 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.5 |
0.5 |
GO:0060825 |
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 0.5 |
9.2 |
GO:0006751 |
glutathione catabolic process(GO:0006751) |
| 0.5 |
1.4 |
GO:0048210 |
Golgi vesicle fusion to target membrane(GO:0048210) |
| 0.5 |
1.4 |
GO:0060380 |
regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.5 |
1.4 |
GO:0046901 |
tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.5 |
3.2 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
| 0.5 |
0.9 |
GO:0097187 |
dentinogenesis(GO:0097187) |
| 0.5 |
2.3 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.5 |
5.0 |
GO:0098795 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.5 |
0.9 |
GO:0007493 |
endodermal cell fate determination(GO:0007493) |
| 0.5 |
3.2 |
GO:0061622 |
glycolytic process through glucose-1-phosphate(GO:0061622) |
| 0.5 |
0.9 |
GO:0061034 |
olfactory bulb mitral cell layer development(GO:0061034) |
| 0.5 |
9.9 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.5 |
1.4 |
GO:1990828 |
response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
| 0.4 |
2.7 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.4 |
4.0 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.4 |
7.1 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.4 |
1.8 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.4 |
0.9 |
GO:0045362 |
regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 0.4 |
1.3 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.4 |
2.6 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.4 |
1.3 |
GO:0045081 |
negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
| 0.4 |
1.3 |
GO:1904235 |
regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
| 0.4 |
1.3 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.4 |
7.8 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.4 |
1.3 |
GO:0010160 |
sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.4 |
1.7 |
GO:0030241 |
skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.4 |
0.9 |
GO:2000118 |
regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.4 |
4.3 |
GO:0033085 |
negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.4 |
4.7 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.4 |
0.8 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.4 |
0.8 |
GO:0060018 |
astrocyte fate commitment(GO:0060018) |
| 0.4 |
1.7 |
GO:2000672 |
regulation of motor neuron apoptotic process(GO:2000671) negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.4 |
2.1 |
GO:0019242 |
methylglyoxal biosynthetic process(GO:0019242) |
| 0.4 |
1.6 |
GO:0060168 |
positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.4 |
1.6 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.4 |
0.8 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.4 |
1.6 |
GO:1904117 |
response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.4 |
9.4 |
GO:1901642 |
nucleoside transmembrane transport(GO:1901642) |
| 0.4 |
2.0 |
GO:0006772 |
thiamine metabolic process(GO:0006772) thiamine diphosphate metabolic process(GO:0042357) |
| 0.4 |
3.3 |
GO:0045007 |
depurination(GO:0045007) |
| 0.4 |
2.4 |
GO:1904219 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.4 |
4.1 |
GO:0015911 |
plasma membrane long-chain fatty acid transport(GO:0015911) |
| 0.4 |
1.6 |
GO:0090289 |
regulation of osteoclast proliferation(GO:0090289) |
| 0.4 |
4.5 |
GO:1990668 |
vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
| 0.4 |
2.8 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.4 |
1.6 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.4 |
1.6 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.4 |
0.8 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.4 |
0.4 |
GO:1902617 |
response to fluoride(GO:1902617) |
| 0.4 |
5.6 |
GO:0043152 |
induction of bacterial agglutination(GO:0043152) |
| 0.4 |
1.2 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.4 |
3.6 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.4 |
4.8 |
GO:0003374 |
dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.4 |
3.2 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.4 |
1.6 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.4 |
0.4 |
GO:0002856 |
negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
| 0.4 |
3.1 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.4 |
16.0 |
GO:0050655 |
dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.4 |
0.8 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.4 |
1.9 |
GO:1902959 |
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) regulation of aspartic-type peptidase activity(GO:1905245) |
| 0.4 |
1.9 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.4 |
1.2 |
GO:0050760 |
negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.4 |
4.2 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.4 |
3.8 |
GO:1900451 |
positive regulation of glutamate receptor signaling pathway(GO:1900451) |
| 0.4 |
6.1 |
GO:0033015 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.4 |
2.7 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.4 |
1.5 |
GO:0071462 |
cellular response to water deprivation(GO:0042631) cellular response to water stimulus(GO:0071462) |
| 0.4 |
1.1 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.4 |
1.1 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.4 |
0.8 |
GO:0001767 |
establishment of lymphocyte polarity(GO:0001767) |
| 0.4 |
3.0 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.4 |
1.5 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.4 |
4.1 |
GO:0071316 |
cellular response to nicotine(GO:0071316) |
| 0.4 |
0.4 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.4 |
3.4 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.4 |
1.9 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
| 0.4 |
0.4 |
GO:0015993 |
molecular hydrogen transport(GO:0015993) |
| 0.4 |
3.0 |
GO:0009133 |
nucleoside diphosphate biosynthetic process(GO:0009133) |
| 0.4 |
1.1 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.4 |
0.7 |
GO:0036509 |
trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.4 |
2.6 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.4 |
1.9 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.4 |
1.5 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.4 |
1.1 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.4 |
1.1 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.4 |
0.7 |
GO:0021879 |
forebrain neuron differentiation(GO:0021879) |
| 0.4 |
1.8 |
GO:0006183 |
GTP biosynthetic process(GO:0006183) |
| 0.4 |
0.7 |
GO:0010760 |
negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.4 |
0.7 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.4 |
19.6 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.4 |
1.5 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.4 |
1.5 |
GO:0046460 |
neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
| 0.4 |
4.7 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.4 |
1.4 |
GO:1905224 |
clathrin-coated pit assembly(GO:1905224) |
| 0.4 |
1.1 |
GO:0061181 |
regulation of chondrocyte development(GO:0061181) |
| 0.4 |
2.5 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.4 |
1.1 |
GO:0021538 |
epithalamus development(GO:0021538) habenula development(GO:0021986) general adaptation syndrome(GO:0051866) |
| 0.4 |
4.7 |
GO:0017187 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.4 |
0.7 |
GO:1903659 |
regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.4 |
0.7 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 0.4 |
3.6 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.4 |
0.7 |
GO:0032242 |
regulation of nucleoside transport(GO:0032242) |
| 0.4 |
1.1 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.4 |
8.5 |
GO:0006554 |
lysine catabolic process(GO:0006554) |
| 0.4 |
3.2 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.4 |
2.5 |
GO:1903026 |
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.4 |
1.8 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.3 |
2.1 |
GO:0010985 |
negative regulation of lipoprotein particle clearance(GO:0010985) |
| 0.3 |
1.4 |
GO:1901079 |
positive regulation of relaxation of muscle(GO:1901079) |
| 0.3 |
0.3 |
GO:0043132 |
NAD transport(GO:0043132) |
| 0.3 |
4.2 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) |
| 0.3 |
9.8 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.3 |
2.4 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.3 |
4.2 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.3 |
1.0 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) |
| 0.3 |
0.7 |
GO:0043313 |
regulation of neutrophil degranulation(GO:0043313) |
| 0.3 |
0.3 |
GO:0003264 |
cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
| 0.3 |
1.0 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.3 |
0.3 |
GO:1900222 |
negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.3 |
2.4 |
GO:0006582 |
melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
| 0.3 |
0.7 |
GO:1903367 |
positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 0.3 |
1.7 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) |
| 0.3 |
2.7 |
GO:0009146 |
purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.3 |
2.4 |
GO:0033239 |
negative regulation of cellular amine metabolic process(GO:0033239) |
| 0.3 |
0.7 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.3 |
2.4 |
GO:0010286 |
heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.3 |
4.1 |
GO:0046549 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.3 |
0.7 |
GO:0048627 |
myoblast development(GO:0048627) |
| 0.3 |
1.7 |
GO:0034224 |
cellular response to zinc ion starvation(GO:0034224) |
| 0.3 |
2.4 |
GO:0019075 |
virus maturation(GO:0019075) |
| 0.3 |
2.7 |
GO:1904385 |
cellular response to angiotensin(GO:1904385) |
| 0.3 |
7.4 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.3 |
2.0 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.3 |
1.0 |
GO:0007418 |
ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) notochord regression(GO:0060032) |
| 0.3 |
9.0 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.3 |
1.7 |
GO:0044821 |
meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.3 |
1.7 |
GO:0097021 |
lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.3 |
0.7 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.3 |
10.5 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.3 |
3.6 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.3 |
1.0 |
GO:0001994 |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.3 |
0.3 |
GO:0009566 |
fertilization(GO:0009566) |
| 0.3 |
1.6 |
GO:0003149 |
membranous septum morphogenesis(GO:0003149) |
| 0.3 |
0.7 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.3 |
2.9 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.3 |
0.3 |
GO:0014805 |
smooth muscle adaptation(GO:0014805) |
| 0.3 |
2.2 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.3 |
0.6 |
GO:0007271 |
synaptic transmission, cholinergic(GO:0007271) |
| 0.3 |
1.0 |
GO:0061580 |
colon epithelial cell migration(GO:0061580) |
| 0.3 |
1.0 |
GO:0043095 |
regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.3 |
6.4 |
GO:0051412 |
response to corticosterone(GO:0051412) |
| 0.3 |
1.9 |
GO:0043627 |
response to estrogen(GO:0043627) |
| 0.3 |
3.5 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.3 |
1.9 |
GO:0051673 |
membrane disruption in other organism(GO:0051673) |
| 0.3 |
0.9 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.3 |
2.8 |
GO:0048295 |
positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.3 |
0.9 |
GO:0048243 |
norepinephrine secretion(GO:0048243) |
| 0.3 |
0.3 |
GO:0045082 |
positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.3 |
0.6 |
GO:1901074 |
regulation of engulfment of apoptotic cell(GO:1901074) |
| 0.3 |
1.9 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.3 |
1.2 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 0.3 |
1.2 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.3 |
2.2 |
GO:0016129 |
phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.3 |
9.0 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.3 |
1.2 |
GO:1903445 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.3 |
22.4 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.3 |
0.6 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.3 |
0.9 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.3 |
0.3 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
| 0.3 |
5.6 |
GO:0045023 |
G0 to G1 transition(GO:0045023) |
| 0.3 |
4.3 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.3 |
1.2 |
GO:0072138 |
mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 0.3 |
2.2 |
GO:0044878 |
mitotic cytokinesis checkpoint(GO:0044878) |
| 0.3 |
11.7 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.3 |
0.6 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.3 |
0.9 |
GO:1904578 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
| 0.3 |
6.1 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.3 |
4.0 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.3 |
0.3 |
GO:0060363 |
cranial suture morphogenesis(GO:0060363) |
| 0.3 |
3.4 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.3 |
0.9 |
GO:0035284 |
rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.3 |
0.6 |
GO:0033693 |
neurofilament bundle assembly(GO:0033693) |
| 0.3 |
0.3 |
GO:0042350 |
GDP-L-fucose biosynthetic process(GO:0042350) |
| 0.3 |
3.9 |
GO:0060180 |
female mating behavior(GO:0060180) |
| 0.3 |
2.4 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.3 |
0.9 |
GO:0035566 |
regulation of metanephros size(GO:0035566) |
| 0.3 |
1.5 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 0.3 |
4.5 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.3 |
0.9 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.3 |
0.3 |
GO:1904798 |
positive regulation of core promoter binding(GO:1904798) |
| 0.3 |
0.3 |
GO:0061525 |
hindgut development(GO:0061525) |
| 0.3 |
0.6 |
GO:0031630 |
regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.3 |
0.6 |
GO:0015813 |
L-glutamate transport(GO:0015813) |
| 0.3 |
2.4 |
GO:0098706 |
ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.3 |
2.1 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.3 |
2.1 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.3 |
2.4 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.3 |
1.2 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.3 |
1.2 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) |
| 0.3 |
0.6 |
GO:0060214 |
endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
| 0.3 |
0.9 |
GO:0031247 |
actin rod assembly(GO:0031247) |
| 0.3 |
0.3 |
GO:1900449 |
regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.3 |
0.3 |
GO:0038033 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.3 |
0.9 |
GO:0010898 |
positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.3 |
1.2 |
GO:0048635 |
negative regulation of muscle organ development(GO:0048635) |
| 0.3 |
0.6 |
GO:1904925 |
positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.3 |
0.6 |
GO:0045356 |
positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
| 0.3 |
1.2 |
GO:0061744 |
motor behavior(GO:0061744) |
| 0.3 |
1.5 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.3 |
2.3 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.3 |
0.9 |
GO:0051970 |
negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.3 |
0.9 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 0.3 |
4.6 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.3 |
0.9 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.3 |
0.9 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.3 |
1.2 |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.3 |
10.9 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.3 |
0.9 |
GO:0003285 |
septum secundum development(GO:0003285) |
| 0.3 |
0.6 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.3 |
2.0 |
GO:0016199 |
axon midline choice point recognition(GO:0016199) |
| 0.3 |
6.9 |
GO:0016024 |
CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.3 |
0.6 |
GO:0060174 |
limb bud formation(GO:0060174) |
| 0.3 |
0.3 |
GO:0010918 |
positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.3 |
0.3 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.3 |
0.6 |
GO:0072312 |
metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.3 |
0.3 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.3 |
1.1 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.3 |
0.8 |
GO:0046543 |
development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
| 0.3 |
1.4 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.3 |
3.4 |
GO:0071321 |
cellular response to cGMP(GO:0071321) |
| 0.3 |
1.1 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.3 |
0.8 |
GO:0070427 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.3 |
1.7 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.3 |
1.1 |
GO:0097688 |
AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.3 |
1.1 |
GO:0009386 |
translational attenuation(GO:0009386) |
| 0.3 |
0.6 |
GO:0060086 |
circadian temperature homeostasis(GO:0060086) |
| 0.3 |
0.3 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.3 |
1.9 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
| 0.3 |
0.3 |
GO:0072190 |
ureter urothelium development(GO:0072190) |
| 0.3 |
0.5 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.3 |
6.0 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.3 |
1.1 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.3 |
2.7 |
GO:0051969 |
regulation of transmission of nerve impulse(GO:0051969) |
| 0.3 |
1.9 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.3 |
0.8 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.3 |
0.8 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) |
| 0.3 |
2.4 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.3 |
0.3 |
GO:2000506 |
negative regulation of energy homeostasis(GO:2000506) |
| 0.3 |
0.8 |
GO:0030821 |
negative regulation of cyclic nucleotide catabolic process(GO:0030806) negative regulation of cAMP catabolic process(GO:0030821) negative regulation of purine nucleotide catabolic process(GO:0033122) regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
| 0.3 |
2.2 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.3 |
1.3 |
GO:0033274 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.3 |
1.6 |
GO:0002634 |
regulation of germinal center formation(GO:0002634) |
| 0.3 |
0.5 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 0.3 |
0.8 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.3 |
5.1 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.3 |
0.3 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
| 0.3 |
1.3 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.3 |
0.5 |
GO:0045626 |
negative regulation of T-helper 1 cell differentiation(GO:0045626) |
| 0.3 |
0.8 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.3 |
1.3 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.3 |
1.9 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.3 |
0.5 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.3 |
8.0 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.3 |
0.5 |
GO:0019521 |
aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.3 |
0.8 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.3 |
4.2 |
GO:0007620 |
copulation(GO:0007620) |
| 0.3 |
1.8 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.3 |
1.3 |
GO:0046465 |
dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.3 |
0.5 |
GO:0097531 |
mast cell migration(GO:0097531) |
| 0.3 |
1.1 |
GO:0019853 |
L-ascorbic acid biosynthetic process(GO:0019853) |
| 0.3 |
0.3 |
GO:0002590 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.3 |
1.8 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.3 |
8.1 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.3 |
2.9 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.3 |
0.3 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.3 |
4.7 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.3 |
3.6 |
GO:0046951 |
ketone body biosynthetic process(GO:0046951) |
| 0.3 |
2.6 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.3 |
12.1 |
GO:0018146 |
keratan sulfate biosynthetic process(GO:0018146) |
| 0.3 |
2.0 |
GO:0098989 |
NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.3 |
0.3 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
| 0.3 |
0.3 |
GO:0002541 |
activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.3 |
1.0 |
GO:0006550 |
isoleucine catabolic process(GO:0006550) |
| 0.3 |
1.3 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.3 |
1.3 |
GO:0046898 |
response to cycloheximide(GO:0046898) |
| 0.3 |
2.8 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.3 |
1.5 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.3 |
1.3 |
GO:0033605 |
positive regulation of dopamine secretion(GO:0033603) positive regulation of catecholamine secretion(GO:0033605) |
| 0.3 |
2.5 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.3 |
2.8 |
GO:0055059 |
asymmetric neuroblast division(GO:0055059) |
| 0.2 |
2.0 |
GO:0072526 |
pyridine-containing compound catabolic process(GO:0072526) |
| 0.2 |
0.7 |
GO:0061026 |
cardiac muscle tissue regeneration(GO:0061026) |
| 0.2 |
2.7 |
GO:0050965 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.2 |
1.2 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.2 |
11.0 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.2 |
4.5 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 0.2 |
5.2 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.2 |
2.0 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.2 |
3.4 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.2 |
2.9 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 |
1.0 |
GO:0036229 |
glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.2 |
3.7 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.2 |
2.0 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.2 |
1.0 |
GO:0046946 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.2 |
0.7 |
GO:0048663 |
neuron fate commitment(GO:0048663) |
| 0.2 |
0.2 |
GO:0097106 |
postsynaptic density organization(GO:0097106) |
| 0.2 |
1.7 |
GO:0051715 |
cytolysis in other organism(GO:0051715) |
| 0.2 |
4.6 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.2 |
0.2 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.2 |
1.2 |
GO:0023035 |
CD40 signaling pathway(GO:0023035) |
| 0.2 |
1.9 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.2 |
0.5 |
GO:0040033 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.2 |
0.5 |
GO:0010002 |
cardioblast differentiation(GO:0010002) |
| 0.2 |
0.7 |
GO:0060078 |
regulation of postsynaptic membrane potential(GO:0060078) |
| 0.2 |
0.5 |
GO:0031587 |
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.2 |
1.0 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.2 |
0.5 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.2 |
2.2 |
GO:0021707 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.2 |
2.9 |
GO:0042340 |
keratan sulfate catabolic process(GO:0042340) |
| 0.2 |
2.6 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.2 |
1.2 |
GO:0007617 |
mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.2 |
2.9 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.2 |
3.1 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.2 |
5.0 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.2 |
1.2 |
GO:0048749 |
compound eye development(GO:0048749) |
| 0.2 |
0.7 |
GO:0035936 |
testosterone secretion(GO:0035936) regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.2 |
0.5 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.2 |
1.2 |
GO:0071873 |
response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
| 0.2 |
1.6 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.2 |
0.5 |
GO:0033625 |
positive regulation of integrin activation(GO:0033625) |
| 0.2 |
0.2 |
GO:0035963 |
response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 0.2 |
3.3 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.2 |
0.5 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.2 |
2.3 |
GO:0045345 |
positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.2 |
1.2 |
GO:0008216 |
spermidine metabolic process(GO:0008216) |
| 0.2 |
0.2 |
GO:0051894 |
positive regulation of focal adhesion assembly(GO:0051894) positive regulation of adherens junction organization(GO:1903393) |
| 0.2 |
1.2 |
GO:0033277 |
abortive mitotic cell cycle(GO:0033277) |
| 0.2 |
2.8 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.2 |
0.7 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.2 |
0.7 |
GO:0009443 |
pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.2 |
1.6 |
GO:0090037 |
positive regulation of protein kinase C signaling(GO:0090037) |
| 0.2 |
2.3 |
GO:1902746 |
regulation of lens fiber cell differentiation(GO:1902746) |
| 0.2 |
3.2 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.2 |
1.1 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.2 |
1.1 |
GO:0002528 |
regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.2 |
1.1 |
GO:1904100 |
regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.2 |
1.1 |
GO:0002292 |
T cell differentiation involved in immune response(GO:0002292) |
| 0.2 |
0.2 |
GO:2000410 |
regulation of thymocyte migration(GO:2000410) |
| 0.2 |
1.4 |
GO:0051005 |
negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.2 |
1.3 |
GO:0019064 |
fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.2 |
5.3 |
GO:0036149 |
phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.2 |
1.3 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.2 |
4.4 |
GO:0060850 |
regulation of transcription involved in cell fate commitment(GO:0060850) |
| 0.2 |
1.3 |
GO:0050819 |
negative regulation of coagulation(GO:0050819) |
| 0.2 |
1.6 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.2 |
2.0 |
GO:0034128 |
negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.2 |
2.0 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.2 |
1.8 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.2 |
0.9 |
GO:0090410 |
malonate catabolic process(GO:0090410) |
| 0.2 |
4.6 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.2 |
0.9 |
GO:0019098 |
reproductive behavior(GO:0019098) |
| 0.2 |
1.5 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.2 |
2.9 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.2 |
0.9 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.2 |
0.2 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.2 |
0.7 |
GO:0086015 |
SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) |
| 0.2 |
0.9 |
GO:0048073 |
regulation of eye pigmentation(GO:0048073) |
| 0.2 |
0.2 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.2 |
0.4 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.2 |
0.4 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.2 |
1.1 |
GO:0072205 |
metanephric collecting duct development(GO:0072205) |
| 0.2 |
0.2 |
GO:0006844 |
acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.2 |
2.2 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.2 |
1.1 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.2 |
1.3 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.2 |
0.2 |
GO:0033058 |
directional locomotion(GO:0033058) |
| 0.2 |
0.9 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.2 |
0.9 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.2 |
0.9 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.2 |
0.4 |
GO:0046778 |
modification by virus of host mRNA processing(GO:0046778) |
| 0.2 |
1.3 |
GO:0001714 |
endodermal cell fate specification(GO:0001714) |
| 0.2 |
1.9 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.2 |
1.3 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.2 |
1.1 |
GO:2001200 |
positive regulation of dendritic cell differentiation(GO:2001200) |
| 0.2 |
2.5 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.2 |
0.8 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.2 |
2.7 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.2 |
1.3 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.2 |
0.6 |
GO:1904781 |
positive regulation of protein localization to centrosome(GO:1904781) |
| 0.2 |
1.1 |
GO:0001692 |
histamine metabolic process(GO:0001692) |
| 0.2 |
0.6 |
GO:0017186 |
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.2 |
0.2 |
GO:0072387 |
flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.2 |
0.6 |
GO:0090190 |
positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.2 |
0.4 |
GO:0038169 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.2 |
0.2 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.2 |
1.0 |
GO:0048333 |
mesodermal cell differentiation(GO:0048333) |
| 0.2 |
1.5 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.2 |
0.4 |
GO:0098712 |
L-glutamate import across plasma membrane(GO:0098712) |
| 0.2 |
0.2 |
GO:0060129 |
thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 0.2 |
1.7 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.2 |
0.8 |
GO:0048200 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.2 |
3.9 |
GO:0001502 |
cartilage condensation(GO:0001502) |
| 0.2 |
1.0 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.2 |
0.8 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.2 |
2.1 |
GO:0003416 |
endochondral bone growth(GO:0003416) |
| 0.2 |
1.2 |
GO:0010714 |
positive regulation of collagen metabolic process(GO:0010714) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.2 |
0.2 |
GO:0098810 |
neurotransmitter reuptake(GO:0098810) |
| 0.2 |
1.0 |
GO:0046078 |
dUMP metabolic process(GO:0046078) |
| 0.2 |
6.3 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.2 |
3.7 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.2 |
1.4 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 0.2 |
0.2 |
GO:0098700 |
neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.2 |
2.0 |
GO:0009583 |
phototransduction(GO:0007602) detection of light stimulus(GO:0009583) |
| 0.2 |
0.8 |
GO:0042424 |
catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
| 0.2 |
4.5 |
GO:0006743 |
ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.2 |
32.4 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.2 |
0.2 |
GO:0035038 |
female pronucleus assembly(GO:0035038) |
| 0.2 |
0.6 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
| 0.2 |
0.6 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.2 |
2.4 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.2 |
2.8 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.2 |
3.2 |
GO:0033127 |
regulation of histone phosphorylation(GO:0033127) |
| 0.2 |
0.8 |
GO:0042723 |
thiamine-containing compound metabolic process(GO:0042723) |
| 0.2 |
6.2 |
GO:0048566 |
embryonic digestive tract development(GO:0048566) |
| 0.2 |
2.4 |
GO:1904714 |
regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.2 |
4.4 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.2 |
1.2 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.2 |
0.6 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) |
| 0.2 |
0.6 |
GO:2000196 |
positive regulation of female gonad development(GO:2000196) |
| 0.2 |
0.6 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.2 |
1.8 |
GO:1903756 |
regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.2 |
0.4 |
GO:2000647 |
negative regulation of neuroblast proliferation(GO:0007406) negative regulation of stem cell proliferation(GO:2000647) |
| 0.2 |
0.2 |
GO:0032627 |
interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
| 0.2 |
0.6 |
GO:1900111 |
positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.2 |
0.4 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.2 |
7.2 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.2 |
0.4 |
GO:0001573 |
ganglioside metabolic process(GO:0001573) |
| 0.2 |
0.6 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.2 |
0.6 |
GO:1990414 |
replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.2 |
0.4 |
GO:0010763 |
positive regulation of fibroblast migration(GO:0010763) |
| 0.2 |
1.0 |
GO:0048845 |
venous blood vessel morphogenesis(GO:0048845) venous blood vessel development(GO:0060841) |
| 0.2 |
0.6 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.2 |
1.2 |
GO:0071395 |
response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.2 |
2.3 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.2 |
1.5 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.2 |
8.0 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.2 |
0.4 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.2 |
1.9 |
GO:0003310 |
pancreatic A cell differentiation(GO:0003310) |
| 0.2 |
0.2 |
GO:0046833 |
positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
| 0.2 |
0.8 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.2 |
2.6 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.2 |
0.4 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.2 |
0.8 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.2 |
0.6 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.2 |
1.9 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.2 |
0.6 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.2 |
0.7 |
GO:2001178 |
mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.2 |
0.2 |
GO:0071934 |
thiamine transmembrane transport(GO:0071934) |
| 0.2 |
1.5 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.2 |
0.6 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.2 |
0.9 |
GO:0038030 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
| 0.2 |
0.7 |
GO:0006114 |
glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
| 0.2 |
0.2 |
GO:0003162 |
atrioventricular node development(GO:0003162) cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
| 0.2 |
1.6 |
GO:0031087 |
deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.2 |
0.7 |
GO:1904806 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.2 |
2.3 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.2 |
0.5 |
GO:0034146 |
toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.2 |
0.7 |
GO:0044029 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.2 |
1.2 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 0.2 |
1.2 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.2 |
0.4 |
GO:0002232 |
leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
| 0.2 |
0.7 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.2 |
6.2 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.2 |
3.7 |
GO:0042417 |
dopamine metabolic process(GO:0042417) |
| 0.2 |
0.7 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.2 |
4.6 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.2 |
1.1 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.2 |
1.6 |
GO:0051593 |
response to folic acid(GO:0051593) |
| 0.2 |
2.6 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.2 |
0.5 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.2 |
2.5 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.2 |
4.9 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.2 |
0.7 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.2 |
0.3 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.2 |
0.9 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.2 |
0.2 |
GO:0010845 |
positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.2 |
1.6 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.2 |
3.3 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.2 |
0.3 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.2 |
0.5 |
GO:2000909 |
regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.2 |
0.2 |
GO:1902527 |
positive regulation of protein monoubiquitination(GO:1902527) |
| 0.2 |
1.2 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.2 |
0.2 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.2 |
1.2 |
GO:0099612 |
protein localization to axon(GO:0099612) |
| 0.2 |
0.2 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.2 |
0.7 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.2 |
0.3 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.2 |
0.7 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.2 |
0.8 |
GO:0052027 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.2 |
1.4 |
GO:0044211 |
CTP salvage(GO:0044211) |
| 0.2 |
2.4 |
GO:0019935 |
cyclic-nucleotide-mediated signaling(GO:0019935) |
| 0.2 |
0.5 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.2 |
1.3 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.2 |
0.8 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.2 |
2.0 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.2 |
1.3 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.2 |
20.0 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.2 |
2.3 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.2 |
0.2 |
GO:0042074 |
cell migration involved in gastrulation(GO:0042074) |
| 0.2 |
0.7 |
GO:0098582 |
innate vocalization behavior(GO:0098582) |
| 0.2 |
0.3 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.2 |
0.2 |
GO:0032329 |
serine transport(GO:0032329) |
| 0.2 |
0.2 |
GO:0060384 |
innervation(GO:0060384) |
| 0.2 |
0.7 |
GO:0045636 |
positive regulation of melanocyte differentiation(GO:0045636) |
| 0.2 |
0.7 |
GO:0098905 |
regulation of bundle of His cell action potential(GO:0098905) |
| 0.2 |
2.7 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.2 |
1.5 |
GO:0060836 |
lymphatic endothelial cell differentiation(GO:0060836) |
| 0.2 |
1.2 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.2 |
3.8 |
GO:0035090 |
maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.2 |
4.3 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.2 |
0.8 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.2 |
1.5 |
GO:0046087 |
cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.2 |
3.6 |
GO:0006068 |
ethanol catabolic process(GO:0006068) |
| 0.2 |
1.6 |
GO:1901970 |
positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.2 |
0.2 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
| 0.2 |
0.8 |
GO:0036152 |
phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.2 |
1.3 |
GO:0010960 |
magnesium ion homeostasis(GO:0010960) |
| 0.2 |
0.6 |
GO:0036269 |
swimming behavior(GO:0036269) |
| 0.2 |
0.3 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 0.2 |
2.1 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.2 |
4.3 |
GO:0061615 |
glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) |
| 0.2 |
3.7 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.2 |
1.7 |
GO:0010968 |
regulation of microtubule nucleation(GO:0010968) |
| 0.2 |
1.4 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.2 |
3.5 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.2 |
2.4 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.2 |
0.3 |
GO:1904220 |
regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.2 |
0.6 |
GO:0044146 |
negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.2 |
2.7 |
GO:0090361 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.2 |
1.6 |
GO:0001973 |
adenosine receptor signaling pathway(GO:0001973) |
| 0.2 |
0.3 |
GO:0046968 |
peptide antigen transport(GO:0046968) |
| 0.2 |
1.4 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.2 |
0.6 |
GO:2000398 |
regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.2 |
0.9 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.2 |
1.5 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.2 |
0.9 |
GO:0051958 |
methotrexate transport(GO:0051958) |
| 0.2 |
2.3 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.2 |
0.9 |
GO:0010820 |
positive regulation of T cell chemotaxis(GO:0010820) |
| 0.2 |
0.5 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.2 |
0.5 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.2 |
1.8 |
GO:0071028 |
nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.2 |
0.9 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.2 |
0.5 |
GO:0010159 |
specification of organ position(GO:0010159) |
| 0.2 |
0.2 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.2 |
0.3 |
GO:0089709 |
histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
| 0.1 |
0.3 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.1 |
1.0 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 |
1.3 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 |
2.5 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
0.3 |
GO:0021540 |
corpus callosum morphogenesis(GO:0021540) |
| 0.1 |
0.1 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.1 |
0.7 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.1 |
0.3 |
GO:1900744 |
regulation of p38MAPK cascade(GO:1900744) |
| 0.1 |
1.0 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.1 |
3.1 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.1 |
0.3 |
GO:0021940 |
positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
| 0.1 |
0.4 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 |
3.6 |
GO:2000249 |
regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.1 |
1.9 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.1 |
1.0 |
GO:0044154 |
histone H3-K14 acetylation(GO:0044154) |
| 0.1 |
1.0 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.1 |
0.4 |
GO:0009756 |
carbohydrate mediated signaling(GO:0009756) |
| 0.1 |
4.6 |
GO:0019934 |
cGMP-mediated signaling(GO:0019934) |
| 0.1 |
1.0 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 |
0.3 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.1 |
7.3 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.1 |
0.3 |
GO:1990834 |
response to odorant(GO:1990834) |
| 0.1 |
2.2 |
GO:0010867 |
positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.1 |
0.8 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.1 |
0.7 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.1 |
0.3 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.1 |
2.1 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.1 |
0.4 |
GO:0000066 |
mitochondrial ornithine transport(GO:0000066) |
| 0.1 |
0.6 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.1 |
0.3 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.1 |
0.6 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.1 |
13.0 |
GO:0071357 |
type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.1 |
0.7 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.1 |
0.4 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 |
0.3 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.1 |
0.3 |
GO:0001845 |
phagolysosome assembly(GO:0001845) |
| 0.1 |
0.3 |
GO:1902003 |
regulation of beta-amyloid formation(GO:1902003) |
| 0.1 |
0.7 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.1 |
0.4 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.1 |
1.4 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.1 |
0.4 |
GO:0061485 |
memory T cell proliferation(GO:0061485) |
| 0.1 |
0.3 |
GO:0055064 |
chloride ion homeostasis(GO:0055064) |
| 0.1 |
1.1 |
GO:0070649 |
polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
| 0.1 |
0.7 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.1 |
0.3 |
GO:1990167 |
protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
| 0.1 |
0.1 |
GO:0035989 |
tendon development(GO:0035989) |
| 0.1 |
2.4 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.1 |
0.1 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.1 |
0.3 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.1 |
0.1 |
GO:0090214 |
spongiotrophoblast layer developmental growth(GO:0090214) |
| 0.1 |
1.5 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.1 |
2.0 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 |
0.3 |
GO:0042415 |
norepinephrine metabolic process(GO:0042415) |
| 0.1 |
0.1 |
GO:1990009 |
retinal cell apoptotic process(GO:1990009) |
| 0.1 |
0.7 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.1 |
0.8 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.1 |
2.1 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.1 |
2.2 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 |
0.3 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.1 |
3.0 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.1 |
0.6 |
GO:0001659 |
temperature homeostasis(GO:0001659) |
| 0.1 |
0.5 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 |
2.3 |
GO:0007597 |
blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 |
0.9 |
GO:0072675 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.1 |
0.6 |
GO:1903969 |
regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
| 0.1 |
0.8 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.1 |
0.1 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.1 |
0.4 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.1 |
1.0 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 |
0.6 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.1 |
0.3 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.1 |
0.5 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.1 |
0.6 |
GO:0021557 |
optic cup structural organization(GO:0003409) oculomotor nerve development(GO:0021557) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 0.1 |
0.4 |
GO:0061591 |
calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.1 |
0.1 |
GO:0097300 |
programmed necrotic cell death(GO:0097300) |
| 0.1 |
1.5 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.1 |
0.4 |
GO:0018208 |
peptidyl-proline modification(GO:0018208) |
| 0.1 |
1.1 |
GO:0070129 |
regulation of mitochondrial translation(GO:0070129) |
| 0.1 |
0.2 |
GO:0060352 |
cell adhesion molecule production(GO:0060352) |
| 0.1 |
0.1 |
GO:0003179 |
heart valve morphogenesis(GO:0003179) |
| 0.1 |
1.0 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 |
0.4 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.1 |
0.2 |
GO:1901258 |
granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) positive regulation of granulocyte colony-stimulating factor production(GO:0071657) positive regulation of macrophage colony-stimulating factor production(GO:1901258) |
| 0.1 |
0.2 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.1 |
4.6 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.1 |
1.6 |
GO:0071467 |
cellular response to pH(GO:0071467) |
| 0.1 |
0.2 |
GO:0018352 |
protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.1 |
0.9 |
GO:0097646 |
calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.1 |
0.9 |
GO:0006119 |
oxidative phosphorylation(GO:0006119) |
| 0.1 |
0.4 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.1 |
0.6 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.1 |
0.2 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 |
2.4 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.1 |
3.9 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.1 |
0.6 |
GO:0090156 |
cellular sphingolipid homeostasis(GO:0090156) |
| 0.1 |
0.5 |
GO:0061107 |
seminal vesicle development(GO:0061107) |
| 0.1 |
1.4 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.1 |
2.8 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.1 |
2.7 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
0.9 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.1 |
0.2 |
GO:0090467 |
L-arginine import(GO:0043091) arginine import(GO:0090467) |
| 0.1 |
0.7 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.1 |
0.3 |
GO:0060988 |
lipid tube assembly(GO:0060988) |
| 0.1 |
4.3 |
GO:0001958 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 |
0.7 |
GO:0034372 |
very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.1 |
0.3 |
GO:1903988 |
regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) spleen trabecula formation(GO:0060345) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
| 0.1 |
0.1 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.1 |
0.6 |
GO:1904252 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.1 |
0.3 |
GO:0071498 |
cellular response to fluid shear stress(GO:0071498) |
| 0.1 |
6.3 |
GO:0018279 |
protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 |
0.5 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.1 |
0.6 |
GO:0019731 |
antibacterial humoral response(GO:0019731) |
| 0.1 |
2.4 |
GO:1904380 |
endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.1 |
0.1 |
GO:0002437 |
inflammatory response to antigenic stimulus(GO:0002437) |
| 0.1 |
0.5 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
| 0.1 |
0.1 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.1 |
0.8 |
GO:0071421 |
manganese ion transmembrane transport(GO:0071421) |
| 0.1 |
1.9 |
GO:0048935 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.1 |
0.7 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 0.1 |
0.1 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.1 |
0.5 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.1 |
0.6 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 0.1 |
1.2 |
GO:0033280 |
response to vitamin D(GO:0033280) |
| 0.1 |
0.8 |
GO:0045586 |
regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.1 |
0.4 |
GO:0009111 |
vitamin catabolic process(GO:0009111) |
| 0.1 |
0.2 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.1 |
0.7 |
GO:1904180 |
negative regulation of membrane depolarization(GO:1904180) |
| 0.1 |
0.6 |
GO:0002074 |
extraocular skeletal muscle development(GO:0002074) |
| 0.1 |
0.4 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.1 |
0.1 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.1 |
1.7 |
GO:0050482 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.1 |
0.1 |
GO:0051573 |
negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.1 |
0.4 |
GO:0007468 |
regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.1 |
2.9 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 |
0.8 |
GO:0098912 |
membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
| 0.1 |
1.0 |
GO:0017182 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.1 |
4.4 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.1 |
0.1 |
GO:0071351 |
interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.1 |
0.2 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.1 |
0.7 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.1 |
0.6 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.1 |
0.7 |
GO:1903281 |
positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.1 |
0.1 |
GO:0036115 |
fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.1 |
0.4 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.1 |
7.9 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.1 |
1.9 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.1 |
0.1 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.1 |
0.5 |
GO:0055070 |
copper ion homeostasis(GO:0055070) |
| 0.1 |
0.1 |
GO:2001183 |
negative regulation of interleukin-12 secretion(GO:2001183) |
| 0.1 |
0.1 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 0.1 |
0.7 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 |
0.7 |
GO:0002407 |
dendritic cell chemotaxis(GO:0002407) |
| 0.1 |
1.0 |
GO:0008306 |
associative learning(GO:0008306) |
| 0.1 |
0.6 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.1 |
0.3 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.1 |
0.3 |
GO:0061430 |
bone trabecula morphogenesis(GO:0061430) |
| 0.1 |
0.5 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.1 |
0.1 |
GO:0008105 |
asymmetric protein localization(GO:0008105) apical protein localization(GO:0045176) |
| 0.1 |
1.9 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 |
1.6 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.1 |
0.2 |
GO:0008595 |
tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.1 |
0.7 |
GO:0060356 |
leucine import(GO:0060356) |
| 0.1 |
0.2 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.1 |
0.7 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.1 |
0.1 |
GO:2001015 |
negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.1 |
0.3 |
GO:0018282 |
metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 0.1 |
0.4 |
GO:0045208 |
MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.1 |
1.4 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.1 |
1.6 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) |
| 0.1 |
2.1 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
0.2 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.1 |
0.5 |
GO:0070901 |
mitochondrial tRNA methylation(GO:0070901) |
| 0.1 |
0.5 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) |
| 0.1 |
1.8 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.1 |
0.7 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 |
1.3 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.1 |
1.2 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 |
0.3 |
GO:0046098 |
guanine catabolic process(GO:0006147) guanine metabolic process(GO:0046098) |
| 0.1 |
0.1 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.1 |
0.3 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.1 |
1.1 |
GO:0048536 |
spleen development(GO:0048536) |
| 0.1 |
0.1 |
GO:1903525 |
regulation of membrane tubulation(GO:1903525) |
| 0.1 |
0.2 |
GO:0002086 |
diaphragm contraction(GO:0002086) |
| 0.1 |
0.1 |
GO:1902075 |
cellular response to salt(GO:1902075) |
| 0.1 |
0.6 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.1 |
0.2 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.1 |
0.1 |
GO:1900369 |
negative regulation of RNA interference(GO:1900369) |
| 0.1 |
0.2 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.1 |
9.3 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.1 |
0.4 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.1 |
3.1 |
GO:0051350 |
negative regulation of lyase activity(GO:0051350) |
| 0.1 |
1.0 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.1 |
2.4 |
GO:0010257 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 |
0.3 |
GO:0071586 |
CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.1 |
0.2 |
GO:0050685 |
positive regulation of mRNA processing(GO:0050685) |
| 0.1 |
0.3 |
GO:0090260 |
filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.1 |
0.1 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.1 |
0.9 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.1 |
0.3 |
GO:0051024 |
positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.1 |
0.5 |
GO:0060662 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.1 |
1.1 |
GO:1900745 |
positive regulation of p38MAPK cascade(GO:1900745) |
| 0.1 |
0.7 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
1.2 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.1 |
0.5 |
GO:0032099 |
negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.1 |
3.8 |
GO:0003009 |
skeletal muscle contraction(GO:0003009) |
| 0.1 |
2.8 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.1 |
2.7 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.1 |
1.7 |
GO:0015695 |
organic cation transport(GO:0015695) |
| 0.1 |
0.3 |
GO:0000393 |
generation of catalytic spliceosome for first transesterification step(GO:0000349) spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.1 |
1.5 |
GO:1990001 |
inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.1 |
0.7 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.1 |
0.9 |
GO:0006707 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 |
2.0 |
GO:0031163 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
0.9 |
GO:0030812 |
negative regulation of nucleotide catabolic process(GO:0030812) |
| 0.1 |
0.4 |
GO:0070525 |
tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.1 |
0.3 |
GO:0046056 |
dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) dADP metabolic process(GO:0046056) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
| 0.1 |
0.2 |
GO:0035456 |
response to interferon-beta(GO:0035456) |
| 0.1 |
6.1 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.1 |
5.6 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.1 |
0.2 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.1 |
0.3 |
GO:1900193 |
regulation of oocyte maturation(GO:1900193) |
| 0.1 |
0.3 |
GO:0032715 |
negative regulation of interleukin-6 production(GO:0032715) |
| 0.1 |
0.6 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.1 |
1.1 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 |
1.5 |
GO:0099601 |
regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.1 |
1.0 |
GO:0007625 |
grooming behavior(GO:0007625) |
| 0.1 |
0.2 |
GO:0060453 |
regulation of gastric acid secretion(GO:0060453) |
| 0.1 |
0.2 |
GO:0048570 |
notochord morphogenesis(GO:0048570) |
| 0.1 |
1.2 |
GO:0000394 |
RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
| 0.1 |
0.5 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.1 |
0.6 |
GO:2000188 |
regulation of cholesterol homeostasis(GO:2000188) |
| 0.1 |
0.5 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.1 |
0.2 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 |
0.3 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.1 |
0.1 |
GO:2000981 |
negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
| 0.1 |
0.3 |
GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.1 |
0.2 |
GO:1902283 |
negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.1 |
0.3 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 |
0.3 |
GO:0035860 |
glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.1 |
0.1 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.1 |
0.1 |
GO:0030185 |
nitric oxide transport(GO:0030185) |
| 0.1 |
0.5 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 0.1 |
0.4 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
1.0 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 |
0.2 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.1 |
0.1 |
GO:0007632 |
visual behavior(GO:0007632) |
| 0.1 |
0.2 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.1 |
1.4 |
GO:0044364 |
killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.1 |
0.5 |
GO:0009068 |
aspartate family amino acid catabolic process(GO:0009068) |
| 0.1 |
1.4 |
GO:0001682 |
tRNA 5'-leader removal(GO:0001682) |
| 0.1 |
0.3 |
GO:0006549 |
isoleucine metabolic process(GO:0006549) |
| 0.1 |
0.2 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.1 |
5.2 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.1 |
0.2 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.1 |
0.6 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.1 |
0.5 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.1 |
0.6 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.1 |
0.2 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.1 |
3.4 |
GO:0006636 |
unsaturated fatty acid biosynthetic process(GO:0006636) |
| 0.1 |
0.3 |
GO:0061303 |
cornea development in camera-type eye(GO:0061303) |
| 0.1 |
0.7 |
GO:0043587 |
tongue morphogenesis(GO:0043587) |
| 0.1 |
1.0 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.1 |
0.5 |
GO:0035994 |
response to muscle stretch(GO:0035994) |
| 0.1 |
0.7 |
GO:0021615 |
glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.1 |
1.2 |
GO:1900151 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.1 |
0.1 |
GO:0071798 |
response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.1 |
0.3 |
GO:1903012 |
positive regulation of bone development(GO:1903012) |
| 0.1 |
0.1 |
GO:1902884 |
positive regulation of response to oxidative stress(GO:1902884) |
| 0.1 |
0.4 |
GO:0045919 |
positive regulation of cytolysis(GO:0045919) |
| 0.1 |
0.2 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.1 |
0.9 |
GO:0018231 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
0.2 |
GO:0051590 |
positive regulation of neurotransmitter transport(GO:0051590) |
| 0.1 |
0.9 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.1 |
0.3 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.1 |
0.2 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.1 |
0.1 |
GO:0042214 |
terpene metabolic process(GO:0042214) |
| 0.1 |
0.6 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.1 |
0.1 |
GO:0042448 |
progesterone metabolic process(GO:0042448) |
| 0.1 |
0.3 |
GO:0070894 |
transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
| 0.1 |
0.3 |
GO:0014898 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 |
0.5 |
GO:0071630 |
nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.1 |
1.7 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.1 |
0.1 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 |
0.3 |
GO:0042904 |
9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.1 |
1.8 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.1 |
1.0 |
GO:0010831 |
positive regulation of myotube differentiation(GO:0010831) |
| 0.1 |
0.1 |
GO:2001057 |
reactive nitrogen species metabolic process(GO:2001057) |
| 0.1 |
1.3 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.1 |
0.7 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 0.1 |
0.3 |
GO:0007567 |
parturition(GO:0007567) |
| 0.1 |
0.1 |
GO:0051167 |
glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.1 |
0.6 |
GO:0071415 |
cellular response to purine-containing compound(GO:0071415) |
| 0.1 |
0.1 |
GO:0006480 |
N-terminal protein amino acid methylation(GO:0006480) |
| 0.1 |
0.2 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.1 |
0.1 |
GO:0051284 |
positive regulation of sequestering of calcium ion(GO:0051284) |
| 0.1 |
0.5 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 |
0.9 |
GO:0030728 |
ovulation(GO:0030728) |
| 0.1 |
6.8 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 |
0.3 |
GO:0010454 |
negative regulation of cell fate commitment(GO:0010454) |
| 0.1 |
0.5 |
GO:0061051 |
positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.1 |
0.3 |
GO:0050712 |
negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.1 |
4.8 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.1 |
0.3 |
GO:0002042 |
cell migration involved in sprouting angiogenesis(GO:0002042) |
| 0.1 |
1.1 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.1 |
0.1 |
GO:0002625 |
regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.1 |
0.3 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.1 |
0.1 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 0.1 |
0.4 |
GO:0071104 |
response to interleukin-9(GO:0071104) |
| 0.1 |
0.3 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.1 |
0.1 |
GO:1901536 |
negative regulation of DNA demethylation(GO:1901536) |
| 0.1 |
2.0 |
GO:0008593 |
regulation of Notch signaling pathway(GO:0008593) |
| 0.1 |
0.1 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 |
0.1 |
GO:0045113 |
regulation of integrin biosynthetic process(GO:0045113) |
| 0.1 |
0.1 |
GO:0030803 |
negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) |
| 0.1 |
0.7 |
GO:0050910 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.1 |
2.7 |
GO:0045669 |
positive regulation of osteoblast differentiation(GO:0045669) |
| 0.1 |
0.1 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.1 |
1.6 |
GO:0015718 |
monocarboxylic acid transport(GO:0015718) |
| 0.1 |
0.1 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.1 |
0.2 |
GO:0046603 |
negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.1 |
0.1 |
GO:0014839 |
myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 0.1 |
0.3 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.1 |
0.1 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 0.1 |
6.9 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.1 |
0.5 |
GO:0016048 |
detection of temperature stimulus(GO:0016048) |
| 0.1 |
0.1 |
GO:0048485 |
sympathetic nervous system development(GO:0048485) |
| 0.1 |
0.2 |
GO:0045897 |
regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
| 0.1 |
0.7 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.1 |
0.5 |
GO:0033141 |
positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 |
0.1 |
GO:0021514 |
ventral spinal cord interneuron differentiation(GO:0021514) |
| 0.1 |
0.2 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.1 |
3.0 |
GO:0006487 |
protein N-linked glycosylation(GO:0006487) |
| 0.1 |
0.7 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 |
0.1 |
GO:0021577 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.1 |
0.1 |
GO:1903430 |
negative regulation of cell maturation(GO:1903430) |
| 0.1 |
0.4 |
GO:0034375 |
high-density lipoprotein particle remodeling(GO:0034375) |
| 0.1 |
0.3 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.1 |
0.3 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.1 |
1.5 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.1 |
1.1 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.1 |
0.1 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.1 |
0.3 |
GO:0010453 |
regulation of cell fate commitment(GO:0010453) |
| 0.1 |
0.2 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 |
0.1 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 |
0.1 |
GO:0045950 |
negative regulation of mitotic recombination(GO:0045950) |
| 0.1 |
0.1 |
GO:0035878 |
nail development(GO:0035878) |
| 0.1 |
0.2 |
GO:0048213 |
Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.1 |
0.1 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.1 |
0.2 |
GO:0033028 |
myeloid cell apoptotic process(GO:0033028) |
| 0.1 |
0.5 |
GO:0071688 |
striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 |
0.1 |
GO:0035249 |
synaptic transmission, glutamatergic(GO:0035249) |
| 0.1 |
0.2 |
GO:1904428 |
negative regulation of tubulin deacetylation(GO:1904428) |
| 0.1 |
0.1 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.1 |
0.2 |
GO:0048664 |
neuron fate determination(GO:0048664) |
| 0.1 |
0.2 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.1 |
0.6 |
GO:0014904 |
myotube cell development(GO:0014904) |
| 0.1 |
0.1 |
GO:1903897 |
regulation of PERK-mediated unfolded protein response(GO:1903897) |
| 0.1 |
0.1 |
GO:0072720 |
response to dithiothreitol(GO:0072720) |
| 0.1 |
0.2 |
GO:0051583 |
dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.1 |
0.1 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.1 |
0.3 |
GO:0021794 |
thalamus development(GO:0021794) |
| 0.1 |
0.2 |
GO:0048265 |
response to pain(GO:0048265) |
| 0.1 |
0.4 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 |
0.6 |
GO:1990573 |
potassium ion import across plasma membrane(GO:1990573) |
| 0.1 |
0.2 |
GO:0051552 |
flavone metabolic process(GO:0051552) |
| 0.1 |
0.4 |
GO:0032026 |
response to magnesium ion(GO:0032026) |
| 0.1 |
0.3 |
GO:0098887 |
neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 0.1 |
0.7 |
GO:0048730 |
hair follicle morphogenesis(GO:0031069) epidermis morphogenesis(GO:0048730) |
| 0.1 |
0.1 |
GO:0060586 |
multicellular organismal iron ion homeostasis(GO:0060586) |
| 0.1 |
1.2 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 |
0.2 |
GO:0021997 |
neural plate axis specification(GO:0021997) |
| 0.0 |
0.1 |
GO:0042737 |
drug catabolic process(GO:0042737) |
| 0.0 |
0.0 |
GO:0086064 |
cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
| 0.0 |
0.7 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.0 |
0.1 |
GO:0009410 |
response to xenobiotic stimulus(GO:0009410) |
| 0.0 |
1.1 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.0 |
0.3 |
GO:0002291 |
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.0 |
0.1 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.0 |
0.2 |
GO:0050858 |
negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
| 0.0 |
0.8 |
GO:1901687 |
glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.0 |
0.8 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 |
0.2 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.0 |
0.2 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 |
0.1 |
GO:0043129 |
surfactant homeostasis(GO:0043129) |
| 0.0 |
0.0 |
GO:0060437 |
lung growth(GO:0060437) |
| 0.0 |
0.2 |
GO:0051610 |
serotonin uptake(GO:0051610) |
| 0.0 |
1.9 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.0 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.0 |
0.2 |
GO:0030201 |
heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.0 |
0.3 |
GO:0071806 |
protein transmembrane transport(GO:0071806) |
| 0.0 |
0.0 |
GO:0018198 |
peptidyl-cysteine modification(GO:0018198) |
| 0.0 |
0.3 |
GO:0006855 |
drug transmembrane transport(GO:0006855) |
| 0.0 |
0.5 |
GO:0048569 |
post-embryonic organ development(GO:0048569) |
| 0.0 |
0.2 |
GO:0060686 |
negative regulation of prostatic bud formation(GO:0060686) |
| 0.0 |
0.2 |
GO:0002933 |
lipid hydroxylation(GO:0002933) |
| 0.0 |
0.8 |
GO:0034308 |
primary alcohol metabolic process(GO:0034308) |
| 0.0 |
0.5 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
| 0.0 |
0.9 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.0 |
0.4 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.0 |
0.3 |
GO:0045061 |
thymic T cell selection(GO:0045061) |
| 0.0 |
0.1 |
GO:0099624 |
atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.0 |
1.6 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 |
0.7 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.0 |
0.1 |
GO:0007343 |
egg activation(GO:0007343) |
| 0.0 |
1.1 |
GO:0035036 |
sperm-egg recognition(GO:0035036) |
| 0.0 |
0.0 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.0 |
0.6 |
GO:0051482 |
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.0 |
0.1 |
GO:0001893 |
maternal placenta development(GO:0001893) |
| 0.0 |
0.1 |
GO:0003228 |
atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.0 |
0.1 |
GO:0060827 |
regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 0.0 |
0.4 |
GO:0010863 |
positive regulation of phospholipase C activity(GO:0010863) |
| 0.0 |
1.0 |
GO:0019369 |
arachidonic acid metabolic process(GO:0019369) |
| 0.0 |
0.0 |
GO:0072077 |
renal vesicle morphogenesis(GO:0072077) |
| 0.0 |
0.2 |
GO:0061015 |
snRNA import into nucleus(GO:0061015) |
| 0.0 |
0.1 |
GO:0031456 |
glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.0 |
0.1 |
GO:0071389 |
cellular response to mineralocorticoid stimulus(GO:0071389) |
| 0.0 |
0.2 |
GO:1903541 |
regulation of exosomal secretion(GO:1903541) |
| 0.0 |
0.0 |
GO:0002467 |
germinal center formation(GO:0002467) |
| 0.0 |
0.0 |
GO:0019060 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.0 |
1.3 |
GO:0032411 |
positive regulation of transporter activity(GO:0032411) |
| 0.0 |
0.0 |
GO:0014052 |
regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 0.0 |
0.0 |
GO:0043092 |
L-amino acid import(GO:0043092) |
| 0.0 |
0.4 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.0 |
0.2 |
GO:0016559 |
peroxisome fission(GO:0016559) |
| 0.0 |
0.1 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.0 |
0.1 |
GO:0031643 |
positive regulation of myelination(GO:0031643) positive regulation of neurological system process(GO:0031646) |
| 0.0 |
0.1 |
GO:0035546 |
interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) |
| 0.0 |
0.3 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.0 |
0.3 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.0 |
0.3 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.0 |
0.3 |
GO:0002675 |
positive regulation of acute inflammatory response(GO:0002675) |
| 0.0 |
0.3 |
GO:0061178 |
regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
| 0.0 |
0.1 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.0 |
0.1 |
GO:1901162 |
serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
| 0.0 |
0.1 |
GO:0009812 |
flavonoid metabolic process(GO:0009812) |
| 0.0 |
0.4 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.0 |
0.1 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) fasciculation of motor neuron axon(GO:0097156) |
| 0.0 |
0.3 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.0 |
0.1 |
GO:0046013 |
T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.0 |
0.3 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.0 |
0.1 |
GO:0006427 |
histidyl-tRNA aminoacylation(GO:0006427) |
| 0.0 |
0.7 |
GO:0043030 |
regulation of macrophage activation(GO:0043030) |
| 0.0 |
0.7 |
GO:0051926 |
negative regulation of calcium ion transport(GO:0051926) |
| 0.0 |
0.0 |
GO:0045590 |
negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.0 |
0.1 |
GO:0002580 |
regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) |
| 0.0 |
2.1 |
GO:0007219 |
Notch signaling pathway(GO:0007219) |
| 0.0 |
0.0 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.0 |
0.1 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.0 |
0.0 |
GO:0044110 |
growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) |
| 0.0 |
0.1 |
GO:0015746 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.0 |
0.1 |
GO:0090240 |
positive regulation of histone H4 acetylation(GO:0090240) |
| 0.0 |
0.4 |
GO:0042984 |
amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.0 |
0.0 |
GO:0001957 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.0 |
0.6 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.0 |
0.1 |
GO:0051037 |
regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.0 |
0.2 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.0 |
0.3 |
GO:0050974 |
detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 0.0 |
0.1 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.0 |
0.1 |
GO:1902571 |
regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.0 |
0.0 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.0 |
0.1 |
GO:0038178 |
complement component C5a signaling pathway(GO:0038178) |
| 0.0 |
0.1 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.0 |
0.4 |
GO:0040036 |
regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
| 0.0 |
0.0 |
GO:0052203 |
modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.0 |
0.5 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.0 |
1.4 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.0 |
0.2 |
GO:0044036 |
cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
| 0.0 |
0.1 |
GO:0032354 |
response to follicle-stimulating hormone(GO:0032354) |
| 0.0 |
0.1 |
GO:0019896 |
axonal transport of mitochondrion(GO:0019896) |
| 0.0 |
0.1 |
GO:0051354 |
negative regulation of oxidoreductase activity(GO:0051354) |
| 0.0 |
0.4 |
GO:0043981 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 |
0.2 |
GO:0015887 |
biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.0 |
0.1 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.0 |
0.3 |
GO:0001708 |
cell fate specification(GO:0001708) |
| 0.0 |
0.1 |
GO:0000454 |
snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.0 |
0.9 |
GO:0007040 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 |
0.2 |
GO:0007196 |
adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.0 |
0.1 |
GO:0044026 |
DNA hypermethylation(GO:0044026) |
| 0.0 |
0.1 |
GO:0042492 |
gamma-delta T cell differentiation(GO:0042492) |
| 0.0 |
0.5 |
GO:0002690 |
positive regulation of leukocyte chemotaxis(GO:0002690) |
| 0.0 |
0.2 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 |
0.1 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.0 |
1.8 |
GO:0032355 |
response to estradiol(GO:0032355) |
| 0.0 |
0.1 |
GO:0072616 |
interleukin-18 secretion(GO:0072616) |
| 0.0 |
0.1 |
GO:0034086 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.0 |
0.0 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.0 |
0.0 |
GO:0003408 |
optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.0 |
0.0 |
GO:0043697 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.0 |
0.1 |
GO:0046092 |
deoxycytidine metabolic process(GO:0046092) |
| 0.0 |
0.0 |
GO:0044406 |
adhesion of symbiont to host(GO:0044406) |
| 0.0 |
0.3 |
GO:0001510 |
RNA methylation(GO:0001510) |
| 0.0 |
0.1 |
GO:0060480 |
lung goblet cell differentiation(GO:0060480) |
| 0.0 |
0.0 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.0 |
0.0 |
GO:0043383 |
negative T cell selection(GO:0043383) |
| 0.0 |
0.4 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.0 |
0.1 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.0 |
0.0 |
GO:0042982 |
amyloid precursor protein metabolic process(GO:0042982) |
| 0.0 |
0.0 |
GO:0038183 |
bile acid signaling pathway(GO:0038183) |
| 0.0 |
0.1 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.0 |
0.1 |
GO:0051124 |
synaptic growth at neuromuscular junction(GO:0051124) |
| 0.0 |
0.3 |
GO:0043113 |
receptor clustering(GO:0043113) |
| 0.0 |
0.1 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) |
| 0.0 |
0.0 |
GO:0001963 |
synaptic transmission, dopaminergic(GO:0001963) |
| 0.0 |
0.1 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.0 |
0.1 |
GO:0010885 |
regulation of cholesterol storage(GO:0010885) |
| 0.0 |
0.1 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.0 |
0.1 |
GO:0042092 |
type 2 immune response(GO:0042092) |
| 0.0 |
0.5 |
GO:1904030 |
negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.0 |
0.1 |
GO:0051968 |
positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 0.0 |
0.1 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.0 |
0.1 |
GO:0043000 |
Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.0 |
0.0 |
GO:0038171 |
cannabinoid signaling pathway(GO:0038171) |
| 0.0 |
0.1 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.0 |
0.0 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.0 |
0.4 |
GO:0003298 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.0 |
GO:0055091 |
phospholipid homeostasis(GO:0055091) |
| 0.0 |
0.3 |
GO:0035640 |
exploration behavior(GO:0035640) |
| 0.0 |
0.1 |
GO:0032203 |
telomere formation via telomerase(GO:0032203) |
| 0.0 |
0.2 |
GO:0034219 |
carbohydrate transmembrane transport(GO:0034219) |
| 0.0 |
0.0 |
GO:0002865 |
type IV hypersensitivity(GO:0001806) negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
| 0.0 |
0.1 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.0 |
0.0 |
GO:0052204 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) modification by host of symbiont molecular function(GO:0052428) |
| 0.0 |
0.1 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.0 |
0.0 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.0 |
0.0 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.0 |
0.0 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.0 |
0.3 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.0 |
0.2 |
GO:0070734 |
histone H3-K27 methylation(GO:0070734) |
| 0.0 |
0.0 |
GO:0045124 |
regulation of bone resorption(GO:0045124) |
| 0.0 |
0.0 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 0.0 |
0.0 |
GO:0014827 |
intestine smooth muscle contraction(GO:0014827) |
| 0.0 |
0.0 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.0 |
0.1 |
GO:0019605 |
butyrate metabolic process(GO:0019605) |
| 0.0 |
0.1 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.0 |
0.4 |
GO:0006026 |
aminoglycan catabolic process(GO:0006026) |
| 0.0 |
0.1 |
GO:0045906 |
negative regulation of vasoconstriction(GO:0045906) |
| 0.0 |
0.2 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.0 |
0.0 |
GO:1903010 |
regulation of bone development(GO:1903010) |
| 0.0 |
0.0 |
GO:0002501 |
peptide antigen assembly with MHC protein complex(GO:0002501) |
| 0.0 |
0.0 |
GO:1904587 |
response to glycoprotein(GO:1904587) response to thyrotropin-releasing hormone(GO:1905225) |
| 0.0 |
0.2 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.0 |
0.1 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.0 |
0.1 |
GO:0090520 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.0 |
0.1 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.0 |
0.1 |
GO:0010836 |
negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.0 |
0.0 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.0 |
0.1 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.0 |
0.1 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.0 |
0.0 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 0.0 |
0.9 |
GO:0036498 |
IRE1-mediated unfolded protein response(GO:0036498) |
| 0.0 |
0.0 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.0 |
0.0 |
GO:0042116 |
macrophage activation(GO:0042116) |
| 0.0 |
0.0 |
GO:2000078 |
positive regulation of type B pancreatic cell development(GO:2000078) |
| 0.0 |
0.0 |
GO:0045605 |
negative regulation of epidermal cell differentiation(GO:0045605) |
| 0.0 |
0.0 |
GO:0007618 |
mating(GO:0007618) |
| 0.0 |
0.0 |
GO:0071711 |
basement membrane organization(GO:0071711) |
| 0.0 |
0.1 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.0 |
0.0 |
GO:0072429 |
response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.0 |
0.0 |
GO:0030815 |
negative regulation of cAMP metabolic process(GO:0030815) |
| 0.0 |
0.0 |
GO:0016062 |
adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
| 0.0 |
0.0 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.0 |
0.5 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.0 |
0.0 |
GO:1900227 |
positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.0 |
0.2 |
GO:0001541 |
ovarian follicle development(GO:0001541) |
| 0.0 |
0.0 |
GO:1901535 |
regulation of DNA demethylation(GO:1901535) |
